在卵泡淋巴瘤中使用奥比努祖马布维护与更好的无进展生存率和可比毒性有关
Renana Robinson1,2, Tamar Berger1,2,3, Tzippy Shochat4
1Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.
European journal of haematology
|February 9, 2026
概括
在现实世界囊性淋巴瘤 (FL) 治疗中,奥比努图祖马布的维护显示出与利图西马布相似的毒性,但更高的无进展生存率 (PFS). 这支持在FL患者的第一线化疗免疫治疗中使用obinutuzumab.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床试验 临床试验
背景情况:
- 使用obinutuzumab (O) 治疗毛囊淋巴瘤 (FL) 的一线化疗免疫疗法在GALLIUM试验中表现出比rituximab (R) 更好的无进展生存期 (PFS),但毒性增加.
- 之前的现实世界数据表明,基于R和O的协议之间的诱导毒性可比.
研究的目的:
- 为了比较Rituximab (R) 与Obinutuzumab (O) 的现实毒性和临床结果,在FL患者的第一线化疗免疫治疗后进行维护治疗.
主要方法:
- 一项多中心回顾性研究分析了接受一线R或O基化疗免疫治疗的FL患者.
- 主要终点是维持治疗6个月内的任何感染.
- 二级终点包括其他毒性,PFS和整体存活率 (OS).
主要成果:
- 分析了134名FL患者 (71名R,63名O),除了R组的并发病率更高之外,具有类似的基线特征.
- 总体感染率是可比的 (50.7%R与61.9%O).
- 虽然R的肺炎和病毒感染较少,但O的输液反应较少. PFS偏爱O (19.7%对4.8%),具有类似的OS.
结论:
- 在FL中使用R和O的现实世界维持疗法显示出类似的整体毒性概况,特定感染类型的变化.
- 与Rituximab相比,Obinutuzumab表现出优越的PFS,与可比的OS相比,支持其在一线FL治疗中的使用,特别是适合患者.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
613
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
613
Comparative Excretory Systems
26.7K
Animals have evolved different strategies for excretion, the removal of waste from the body. Most waste must be dissolved in water to be excreted, so an animal’s excretory strategy directly affects its water balance.
26.7K
Survival Curves
727
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
727
Survival Tree
434
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
434
Maintenance of the ES Cell State
2.8K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K
Introduction To Survival Analysis
830
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
830


